Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations: Update on Genotype-Phenotype Correlation and Validation of a High-Resolution Melting Assay for Mutational Testing

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Journal of Surgical Pathology

• Publication date

  2013-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/PAS.0b013e3182986b88PMID 24061512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Novel Germline KIT Mutation (p.L576P) in a Family Presenting With Juvenile Onset of Multiple Gastrointestinal Stromal Tumors, Skin Hyperpigmentations, and Esophageal Stenosis

  2013cited by this paper
• A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del)

  2013cited by this paper
• Activating PDGFRA mutations in inflammatory fibroid polyps occur in exons 12, 14 and 18 and are associated with tumour localization

  2012cited by this paper
• Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2012cited by this paper
• Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.

  2012cited by this paper
• MicroRNA expression profile of gastrointestinal stromal tumors is distinguished by 14q loss and anatomic site

  2010cited by this paper
• Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors

  2010cited by this paper
• Molecular and Clinicopathologic Characterization of Gastrointestinal Stromal Tumors (GISTs) of Small Size

  2010cited by this paper
• Pathological characteristics of gastrointestinal stromal tumours with PDGFRA mutations

  2009cited by this paper
• The role of KRAS mutation testing in the management of patients with metastatic colorectal cancer.

  2009cited by this paper
• Epidemiology and molecular biology of gastrointestinal stromal tumors (GISTs): a population-based study in the South of Switzerland, 1999-2005.

  2008cited by this paper
• KIT exon 11 codon 557/558 deletion/insertion mutations define a subset of gastrointestinal stromal tumors with malignant potential.

  2008cited by this paper
• Multiple Primary Sporadic Gastrointestinal Stromal Tumors in the Adult: An Underestimated Entity

  2008cited by this paper
• Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 cases

  2008cited by this paper
• Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours

  2008cited by this paper
• The Catalogue of Somatic Mutations in Cancer (COSMIC)

  2008cited by this paper
• Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series

  2007cited by this paper
• Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor.

  2007cited by this paper
• Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumors

  2007cited by this paper
• KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs).

  2006cited by this paper
• Gastrointestinal Stromal Tumors of the Jejunum and Ileum: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 906 Cases Before Imatinib With Long-term Follow-up

  2006cited by this paper
• Detection of a new mutation in KIT exon 9 in a gastrointestinal stromal tumor

  2006cited by this paper
• KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.

  2006cited by this paper
• Gastrointestinal stromal tumors: pathology and prognosis at different sites.

  2006cited by this paper
• PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib.

  2005cited by this paper
• Clinical and molecular characteristics of pediatric gastrointestinal stromal tumors (GISTs)

  2005cited by this paper
• Gastrointestinal Stromal Tumors of the Stomach: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 1765 Cases With Long-term Follow-up

  2005cited by this paper
• Prognostic Role of E2F1 and Members of the CDKN2A Network in Gastrointestinal Stromal Tumors

  2005cited by this paper
• Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).

  2005cited by this paper
• Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors.

  2003cited by this paper
• KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal origin.

  2003cited by this paper
• Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

  2003cited by this paper
• Deletion of Trp‐557 and Lys‐558 in the juxtamembrane domain of the c‐kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors

  2003cited by this paper
• Gain‐of‐function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours

  2001cited by this paper
• Mutations in c‐kit Gene Exons 9 and 13 in Gastrointestinal Stromal Tumors among Japanese

  2001cited by this paper
• Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases.

  2000cited by this paper
• Soft Tissue Sarcoma, Version 1.2021 Featured Updates to the NCCN Guidelines

  year unknowncited by this paper

• Mutational landscape of gastrointestinal stromal tumors using next-generation sequencing of a 73-gene panel

  2025cites this paper
• Molecular Profiling of KIT/PDGFRA-Mutant and Wild-Type Gastrointestinal Stromal Tumors (GISTs) with Clinicopathological Correlation: An 18-Year Experience at a Tertiary Center in Kuwait

  2024cites this paper
• Current Practice in the Diagnosis and Treatment of Localized Gastric Gastrointestinal Stromal Tumors

  2024cites this paper
• Gene Mutations in Gastrointestinal Stromal Tumors: Advances in Treatment and Mechanism Research

  2024cites this paper
• Potential of radiomics in the diagnosis of gastrointestinal stromal tumors: a literature review.

  2024cites this paper
• KIT A502_Y503 duplication mutation serves as a potential and universal target for neoantigen peptide in Chinese GIST patients

  2023cites this paper
• Molecular Tailored Therapeutic Options for Advanced Gastrointestinal Stromal Tumors (GISTs): Current Practice and Future Perspectives

  2023cites this paper
• Predictive Value of a Radiomics Nomogram Model Based on Contrast-Enhanced Computed Tomography for KIT Exon 9 Gene Mutation in Gastrointestinal Stromal Tumors

  2023influential citation
• New treatment strategies for advanced-stage gastrointestinal stromal tumours

  2022cites this paper
• Prevalence of CKIT and PDGFRA Mutation in Gastrointestinal Stromal Tumors among Filipinos

  2022cites this paper
• KIT Exon 9-Mutated Gastrointestinal Stromal Tumours: Biology and Treatment

  2022cites this paper
• Gastrointestinal Stromal Tumors (GIST): A Population-Based Study Using the SEER Database, including Management and Recent Advances in Targeted Therapy

  2022cites this paper
• HAND1 and BARX1 Act as Transcriptional and Anatomic Determinants of Malignancy in Gastrointestinal Stromal Tumor

  2021cites this paper
• Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study

  2021cites this paper
• Prognostic indicators for gastrointestinal stromal tumors: a review

  2020cites this paper
• Clinical significance of the molecular heterogeneity of gastrointestinal stromal tumors and related research: A systematic review.

  2020cites this paper
• Somatic pharmacogenomics of gastrointestinal stromal tumor

  2019influential citation
• Gastrointestinale Stromatumoren

  2018cites this paper
• Predictive Biomarkers and Targeted Therapies in Sarcomas

  2018cites this paper
• Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment

  2018cites this paper
• Perspectives on the evolving state of the art management of gastrointestinal stromal tumours.

  2018cites this paper
• Gastrointestinale Stromatumoren

  2018cites this paper
• Prognostički čimbenici u gastrointestinalnim stromalnim tumorima

  2018cites this paper
• Surgical Pathology of Gastrointestinal Stromal Tumors: Practical Implications of Morphologic and Molecular Heterogeneity for Precision Medicine.

  2017cites this paper
• Gastrointestinale Stromatumoren des Magens und ihre Vorstufen

  2017cites this paper
• The big, the bad, and the exon 11: adjuvant imatinib for all gastro-intestinal stromal tumors or just the ugly?

  2017cites this paper
• Molecular subtypes of gastrointestinal stromal tumors and their prognostic and therapeutic implications.

  2017cites this paper
• Current Standard and Future Perspectives in the Treatment of Gastrointestinal Stromal Tumors

  2017cites this paper
• KIT-negative gastrointestinal stromal tumor presenting as omental nodule with silent PDGFRA mutation identified by next generation sequencing (NGS)

  2017cites this paper
• Gastrointestinal Stromal Tumors (GISTs) of the Liver

  2017cites this paper
• Desarrollo de un método de diagnóstico de los tumores del estroma gastrointestinal (GIST)

  2016influential citation
• mutation status in gastrointestinal stromal tumors

  2016cites this paper
• Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial

  2016cites this paper
• Molecular genetic features and risk assessment in a series of 30 patients who underwent an operation for gastrointestinal stormal tumours.

  2016cites this paper
• Molecular cytology genotyping of primary and metastatic GI stromal tumors by using a custom two-gene targeted next-generation sequencing panel with therapeutic intent.

  2016cites this paper
• Molecular genetic features and risk assessment in a series of 30 patients who underwent an operation for gastrointestinal stromal tumours ORIGINAL ARTICLE

  2016cites this paper
• Genetic basis of a solitary familial plexiform neurofibroma without verified associated neurofibromatosis

  2016cites this paper
• Gastrointestinal Stromal Tumor of the Adrenal Gland:A Case Report and Review of the Literature

  2015cites this paper
• Genetics of Gastrointestinal Stromal Tumors: A Heterogeneous Family of Tumors?

  2015cites this paper
• Massively parallel sequencing fails to detect minor resistant subclones in tissue samples prior to tyrosine kinase inhibitor therapy

  2015cites this paper
• Kinase genotype analysis of gastric gastrointestinal stromal tumor cytology samples using targeted next-generation sequencing.

  2015cites this paper
• [Gastrointestinal stromal tumours (GIST)--development in pathology, surgery and medical therapy. Developed during the 10th German GIST-meeting, Göttingen].

  2015cites this paper
• Clinicopathological significance of c-KIT mutation in gastrointestinal stromal tumors: a systematic review and meta-analysis

  2015cites this paper
• Molekularpathologie der Weichgewebstumoren: Beitrag zur Diagnostik und Therapieprädiktion

  2015cites this paper
• Follow-up strategies for patients with gastrointestinal stromal tumour treated with or without adjuvant imatinib after surgery.

  2015cites this paper
• KIT and PDGFRA mutations and the risk of GI stromal tumor recurrence.

  2015cites this paper
• Молекулярно-генетические особенности и маркеры гастроинтестинальных стромальных опухолей

  2015cites this paper
• [Molecular pathology of soft tissue tumors: Contribution to diagnosis and therapy prediction].

  2015cites this paper
• Gastrointestinale Stromatumoren (GIST) – Neues zu Pathologie, Chirurgie und medikamentöser Therapie

  2015cites this paper
• Übersicht – Molekulare Diagnostik bei gastrointestinalen Stromatumoren

  2014cites this paper
• Section IV: non-small cell lung cancer and malignant melanoma.

  2014cites this paper
• Tumor Genotype Is an Independent Prognostic Factor in Primary Gastrointestinal Stromal Tumors of Gastric Origin: A European Multicenter Analysis Based on ConticaGIST

  2014cites this paper
• Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412.

  2014cites this paper
• High-resolution melting analysis is a sensitive diagnostic tool to detect imatinib-resistant and imatinib-sensitive PDGFRA exon 18 mutations in gastrointestinal stromal tumors.

  2014cites this paper
• Oncotargets and Therapy Dovepress

  year unknowncites this paper